Job cut
Pfizer Trims 200 Positions at Michigan COVID Plant During Cost-Saving Measures
The decline in demand for its COVID-19 treatments has prompted Pfizer to initiate a cost-reduction strategy across the company, which ...
Kronos Bio Slashes Staff by 19% to Fund Upcoming Solid Tumor Trial
Kronos Bio is undergoing a strategic reorganization, including a staff reduction of 19%, following promising early trial results for a ...
Amgen to cut 350 jobs after acquiring Horizon for $28 billion
Recently, in the aftermath of Amgen’s substantial $27.8 billion acquisition of Horizon, unveiled in December and finalized this month, these ...
Sana slashes staff and drops in vivo CAR-T program to cut costs
Sana Biotechnology, amid challenging stock performance, is undergoing its second significant restructuring in less than a year. This move involves ...
uniQure cuts staff and R&D projects to extend gene therapy cash runway
uniQure, a biotech company focused on gene therapy, is implementing a significant workforce reduction as part of a strategic restructuring ...
NexImmune slashes staff again as cash crunch looms over its nanoparticle platform
NexImmune, the immunotherapy biotech, is once again in the spotlight for layoff as it nears the end of its financial ...
Biogen Buys Reata and Skyclarys for $7.3B, Cuts Jobs
During a quarterly earnings call, Biogen CEO Chris Viehbacher unexpectedly mentioned that the company had around $7.3 billion in cash. ...
